Haiti vs Yemen: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Haiti
39.0%
in 2025
Yemen
39.0%
in 2025
Haiti rank
160th
Yemen rank
160th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Haiti
- Yemen
How they compare
Haiti currently reports 39.0% against 39.0% in Yemen, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Yemen ahead.
Haiti ranks 160th and Yemen ranks 160th of 194 countries.
Yemen has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Haiti | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 3.9% | 54.0% | 50.1% | Yemen |
| 2020s | 46.2% | 48.7% | 2.5% | Yemen |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Haiti or Yemen?
- Haiti, at 39.0% against 39.0% in Yemen as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Haiti and Yemen?
- 0.0%, with Haiti ahead.
- How many years of comparable data are there for Haiti and Yemen?
- 18 years are reported by both, from 2008 to 2025.
- How do Haiti and Yemen rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Haiti ranks 160th and Yemen ranks 160th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.